BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23635730)

  • 21. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
    Hinz EK; Murthy A; Wang B; Ryan N; Ades V
    Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm
    Perelló-Capó J; Estadella-Tarriel J; Gich-Saladich I; Bailón-Queiruga M; Llurba-Olivé E; Calaf-Alsina J
    Contraception; 2023 Nov; 127():110127. PubMed ID: 37487868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term utilization and continuation of intrauterine devices.
    Diedrich JT; Madden T; Zhao Q; Peipert JF
    Am J Obstet Gynecol; 2015 Dec; 213(6):822.e1-6. PubMed ID: 26409157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of age and parity with intrauterine device expulsion.
    Madden T; McNicholas C; Zhao Q; Secura GM; Eisenberg DL; Peipert JF
    Obstet Gynecol; 2014 Oct; 124(4):718-726. PubMed ID: 25198262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L
    J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
    Andersson K; Odlind V; Rybo G
    Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
    Rowe P; Farley T; Peregoudov A; Piaggio G; Boccard S; Landoulsi S; Meirik O;
    Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study.
    Phillips SJ; Hofler LG; Modest AM; Harvey LFB; Wu LH; Hacker MR
    Am J Obstet Gynecol; 2017 Jul; 217(1):57.e1-57.e6. PubMed ID: 28315664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC; Riley HEM; Curtis KM
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrauterine device use among women with ovarian cancer: a systematic review.
    Zapata LB; Whiteman MK; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):38-40. PubMed ID: 20682141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine contraception in nulliparous women: a prospective survey.
    Hall AM; Kutler BA
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):36-42. PubMed ID: 25854550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.